Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 372

Results For "UST"

3772 News Found

Lonza and Immunitas announce manufacturing agreement
News | April 18, 2021

Lonza and Immunitas announce manufacturing agreement

Lonza's Ibex Design end-to-end offering will cover the development stages of IMT-009 from development candidates through early clinical studies


Aceto acquires specialty exipients company A&C
News | April 16, 2021

Aceto acquires specialty exipients company A&C

Acquisition of A&C expands Aceto’s Western manufacturing footprint


IMPCL revenue crosses Rs. 160 crore
News | April 15, 2021

IMPCL revenue crosses Rs. 160 crore

Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum


Pharma PLI to increase exports
Policy | April 14, 2021

Pharma PLI to increase exports

Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28


NATCO receives approval for Ibrutinib tablets from ANDA
News | April 11, 2021

NATCO receives approval for Ibrutinib tablets from ANDA

The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths


Aurore to merge with Solara in an all-stock transaction
News | April 10, 2021

Aurore to merge with Solara in an all-stock transaction

The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions


Pharma sector has both brainpower and manpower to drive growth: Mandaviya
Policy | April 09, 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable


Dr. Reddy's Laboratories launches Sapropterin Dihydrochloride powder for oral solution in US
News | April 08, 2021

Dr. Reddy's Laboratories launches Sapropterin Dihydrochloride powder for oral solution in US

Sapropterin dihydrochloride powder for oral solution is available in 100 mg unit dose


GlaxoSmithKline approves sale of Vemgal plant
News | April 05, 2021

GlaxoSmithKline approves sale of Vemgal plant

Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India